Cholesterol and Pharmacogenetic Study

PHASE4CompletedINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

March 31, 2002

Primary Completion Date

October 31, 2004

Conditions
HyperlipidemiaHypercholesterolemiaCoronary Heart DiseaseCardiovascular Disease
Interventions
DRUG

Simvastatin

40mg/day

Trial Locations (1)

94110

San Francisco General Hospital, San Francisco

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

San Francisco General Hospital

OTHER

collaborator

University of California, Los Angeles

OTHER

collaborator

Cedars-Sinai Medical Center

OTHER

collaborator

University of Washington

OTHER

collaborator

Duke University

OTHER

lead

UCSF Benioff Children's Hospital Oakland

OTHER